Example: Heart Attack

Search clinical trials for: Cangrelor

Total 35 results

    • NCT03043274
      Terminated
      Cangrelor in ST-Elevation Myocardial Infarction to Decrease Infarct Size
      Conditions: STEMI - ST Elevation Myocardial Infarction
    • NCT04634162
      Recruiting
      PD and PK Profiles of Switching Between Cangrelor and Ticagrelor Following Ticagrelor Pre-treatment
      Conditions: Coronary Artery Disease
    • NCT02943369
      Completed
      Cangrelor Following Ticagrelor Loading vs Ticagrelor Loading Alone in STEMI
      Conditions: STEMI
    • NCT03862651
      Not yet recruiting
      Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery (MONET BRIDGE)
      Conditions: Platelet Aggregation Inhibitors
    • NCT03247738
      Completed
      Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI
      Conditions: ST Segment Elevation Myocardial Infarction; Percutaneous Coronary Intervention
    • NCT04668144
      Recruiting
      Pharmacodynamic and Pharmacokinetic of Switching From Cangrelor to Prasugrel in ACS Patients Undergoing PCI
      Conditions: Coronary Artery Disease; Acute Coronary Syndrome
    • NCT02765633
      Completed
      Cangrelor Neonatal PK/PD and Safety Study
      Conditions: Partial Obstruction of Systemic to Pulmonary Artery Shunt; Complete Obstruction of Systemic to Pulmonary Artery Shunt
    • NCT04005729
      Recruiting
      Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCI
      Conditions: Out-Of-Hospital Cardiac Arrest; Acute Coronary Syndrome
    • NCT04138641
      Completed
      Dutch Cangrelor Registry
      Conditions: STEMI - ST Elevation Myocardial Infarction; NSTEMI - Non-ST Segment Elevation MI; Coronary Artery Disease
    • NCT03102723
      Unknown status
      Platelet Inhibition to Target Reperfusion Injury
      Conditions: STEMI
    • NCT03182855
      Unknown status
      Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI
      Conditions: Acute Coronary Syndrome; Myocardial Infarction; STEMI - ST Elevation Myocardial Infarction
    • NCT01766466
      Completed
      Cangrelor Ticagrelor Transition Study
      Conditions: Coronary Artery Disease
    • NCT02733341
      Completed
      The Effect of IV Cangrelor and Oral Ticagrelor Study
      Conditions: Acute Coronary Syndrome (ACS); High On-treatment Platelet Reactivity (HTPR); Microvascular Obstruction (MVO); ST-segment Elevation Myocardial Infarction (STEMI); Thrombolysis in Myocardial Infarction (TIMI); Unstable Angina (UA)
    • NCT03048019
      Unknown status
      Comparison of Pharmacodynamic Effects of Tirofiban vs. Cangrelor in N-STEMI Patients Undergoing Percutaneous Coronary Intervention
      Conditions: Non-ST Elevation Myocardial Infarction (NSTEMI)
    • NCT01852019
      Completed
      Cangrelor Prasugrel Transition Study
      Conditions: Coronary Artery Disease
    • NCT02978040
      Completed
      Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.
      Conditions: Coronary Artery Disease; STEMI - ST Elevation Myocardial Infarction
    • NCT00102674
      Completed
      Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor
      Conditions: Healthy
    • NCT00767507
      Completed
      Maintenance of Platelet Inhibition With Cangrelor
      Conditions: Acute Coronary Syndrome (ACS)
    • NCT03551964
      Recruiting
      Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction
      Conditions: Acute Myocardial Infarction; Cardiogenic Shock
    • NCT01156571
      Completed
      A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)
      Conditions: Atherosclerosis; Percutaneous Coronary Intervention; Acute Coronary Syndrome
    • NCT01979445
      Completed
      Cangrelor to Clopidogrel or Prasugrel Transition Study
      Conditions: Coronary Artery Disease (CAD)
    • NCT00385138
      Terminated
      Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.
      Conditions: Atherosclerosis; Acute Coronary Syndrome (ACS)
    • NCT03273075
      Recruiting
      Add-on Cangrelor in STEMI-triggered Cardiac Arrest
      Conditions: Cardiopulmonary Arrest With Successful Resuscitation; ACS - Acute Coronary Syndrome; Hypothermia, Induced
    • NCT00305162
      Terminated
      A Clinical Trial to Demonstrate the Efficacy of Cangrelor
      Conditions: Myocardial Infarction (MI); Acute Coronary Syndromes (ACS)
    • NCT04667078
      Not yet recruiting
      REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts
      Conditions: Acute Ischemia
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations